MEFV gene 3'-UTR Alu repeat polymorphisms in patients with familial Mediterranean fever

D Ustek1, C Ekmekçi, B Oku

  • 1Department of Genetics, Institute for Experimental Medicine, Istanbul Faculty of Medicine, Istanbul, Turkey.

Abstract

Insights

Familial Mediterranean fever (FMF) is linked to MEFV gene variations. This study found 3'-UTR polymorphisms associated with FMF in patients lacking coding region mutations, suggesting a role in gene expression regulation.

Area of Science:

  • Genetics
  • Molecular Biology
  • Immunology

Background:

  • Familial Mediterranean fever (FMF) is an autoinflammatory disorder inherited in an autosomal recessive pattern.
  • It is caused by mutations in the pyrin-encoding MEFV gene, detectable in most FMF patients.
  • However, a subset of FMF patients exhibits the phenotype without detectable coding region mutations.

Purpose of the Study:

  • To investigate promoter and 3 -UTR polymorphisms of the MEFV gene.
  • To identify variations in FMF patients with no coding region mutations.
  • To explore the potential role of these variations in regulating MEFV gene expression.

Main Methods:

  • Genotyping of 289 FMF patients and 103 healthy controls for common MEFV mutations.
  • Screening of MEFV coding regions in mutation-negative patients using single-stranded conformation polymorphism and DNA sequencing.
  • Analysis of MEFV promoter and 3 -UTR regions, including haplotype analysis of 3 -UTR single nucleotide polymorphisms (SNPs).

Main Results:

  • 14.5% of FMF patients had no detectable mutations among the five common ones.
  • 36 patients (12.5%) lacked any identified coding region mutations.
  • A significant association was found between 3 -UTR polymorphisms (in two haplotypes) and FMF patients with no coding region mutations (75% vs. 48.5%, p=0.006).

Conclusions:

  • The study identified MEFV 3 -UTR polymorphisms clustered in two haplotypes.
  • A genetic association exists between these 3 -UTR polymorphisms and FMF patients lacking coding region mutations.
  • These findings suggest that 3 -UTR sequences may play a role in regulating MEFV gene expression.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...